biote Corp.·4

May 23, 4:06 PM ET

Jacoby Dana Lynn 4

4 · biote Corp. · Filed May 23, 2024

Insider Transaction Report

Form 4
Period: 2024-05-21
Transactions
  • Exercise/Conversion

    Deferred Settlement RSU

    2024-05-2111,5950 total
    Class A Common Stock (11,595 underlying)
  • Exercise/Conversion

    Class A Common Stock

    2024-05-21+11,59550,970 total
  • Award

    Deferred Settlement RSU

    2024-05-21+12,99412,994 total
    Class A Common Stock (12,994 underlying)
  • Award

    Stock Option (Right to Buy)

    2024-05-21+65,258143,763 total
    Exercise: $5.57Exp: 2034-05-20Class A Common Stock (65,258 underlying)
Footnotes (4)
  • [F1]Each Deferred Settlement RSU is the economic equivalent of one share of Issuer Class A Common Stock.
  • [F2]The Deferred Settlement RSUs are fully vested upon grant, but settlement will be deferred until the earlier of calendar year 2024 or the date of the Reporting Person's separation from service.
  • [F3]The Deferred Settlement RSUs are fully vested upon grant, but settlement will be deferred until the earlier of calendar year 2025 or the date of the Reporting Person's separation from service.
  • [F4]All shares subject to the option award shall vest on the earlier of May 21, 2025 or the day prior to the date of the Issuer's 2025 Annual Meeting of Stockholders, subject to the Reporting Person's continuous service through such vesting date.

Documents

1 file
  • 4
    primarydocument.xmlPrimary

    PRIMARY DOCUMENT